HutchMED (China) LIMITED (HMDCF) Operating cash flow 2016–2025
HutchMED (China) LIMITED (HMDCF) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$64.7MFY2025 · since FY2016: -$9.6M → -$64.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$64.7M | -13109.5% |
| FY2024 | $497,000 | -99.8% |
| FY2023 | $219.3M | +181.6% |
| FY2022 | -$268.6M | -31.5% |
| FY2021 | -$204.2M | -229.0% |
| FY2020 | -$62.1M | +23.3% |
| FY2019 | -$80.9M | -146.3% |
| FY2018 | -$32.8M | -267.3% |
| FY2017 | -$8.9M | +6.5% |
| FY2016 | -$9.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More HMDCF financial trends
HMDCF RevenueHMDCF Net incomeHMDCF Net marginHMDCF Gross profitHMDCF Gross marginHMDCF Operating incomeHMDCF Operating marginHMDCF Free cash flowHMDCF Capital expendituresHMDCF Return on equityHMDCF Stock buybacksHMDCF Dividends paidHMDCF Total assetsHMDCF Total liabilitiesHMDCF Shareholders’ equityHMDCF overview →